Compare FIG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIG | PEN |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 14.0B |
| IPO Year | 2025 | 2015 |
| Metric | FIG | PEN |
|---|---|---|
| Price | $22.87 | $339.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 18 |
| Target Price | $55.22 | ★ $350.94 |
| AVG Volume (30 Days) | ★ 13.2M | 1.4M |
| Earning Date | 02-18-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | N/A | ★ 4.14 |
| Revenue | $968,957,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $40.99 | $17.03 |
| Revenue Next Year | $23.11 | $14.38 |
| P/E Ratio | ★ N/A | $81.99 |
| Revenue Growth | ★ 91.92 | 14.61 |
| 52 Week Low | $19.85 | $221.26 |
| 52 Week High | $142.92 | $362.41 |
| Indicator | FIG | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.62 | 50.32 |
| Support Level | $21.15 | $337.63 |
| Resistance Level | $25.17 | $340.92 |
| Average True Range (ATR) | 1.93 | 3.40 |
| MACD | 0.13 | -3.48 |
| Stochastic Oscillator | 29.01 | 7.13 |
Figma Inc is engaged in transforming ideas into digital products and experiences. The group focuses on the entire software creation lifecycle, enabling it to quickly launch new products on Figma's browser-based platform and reinforcing its belief that design extends well beyond a single step or role. The company adopts an expansive view, as design is more than how something looks, feels, or works. It derives its revenue from sales of subscriptions for access to its platform.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.